Investing in Modern and Advanced Treatment Devices to Help Treatment-Resistant Patient Populations
HIT Consultant
AUGUST 8, 2023
Intravenous (IV) ketamine and intranasal esketamine also have demonstrated efficacy for TRD, but there is not yet sufficient evidence for maintenance treatments, they require anesthesia or nurse monitoring, and patients cannot drive home right after a treatment. Ten years later, Mark S. George, M.D.
Let's personalize your content